The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
出版年份 2013 全文链接
标题
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
作者
关键词
-
出版物
NEURO-ONCOLOGY
Volume 15, Issue 9, Pages 1200-1211
出版商
Oxford University Press (OUP)
发表日期
2013-05-31
DOI
10.1093/neuonc/not054
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor
- (2012) Anne E. Powell et al. CELL
- Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling
- (2012) Vivian W. Y. Wong et al. NATURE CELL BIOLOGY
- Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
- (2011) Anna Golebiewska et al. Cell Stem Cell
- Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ER -Positive Breast Cancer
- (2011) S. R. Krig et al. MOLECULAR CANCER RESEARCH
- Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
- (2011) P. C. De Witt Hamer NEURO-ONCOLOGY
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
- (2011) Olivier Keunen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A reproducible brain tumour model established from human glioblastoma biopsies
- (2010) Jian Wang et al. BMC CANCER
- Past, Present and Future of Targeted Therapy in Solid Tumors
- (2010) A. Palazzo et al. CURRENT CANCER DRUG TARGETS
- Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1
- (2010) Wei Yi et al. EXPERIMENTAL CELL RESEARCH
- LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer
- (2010) Marcus Thomasson et al. INTERNATIONAL JOURNAL OF CANCER
- Ciliary Neurotrophic Factor Cell-Based Delivery Prevents Synaptic Impairment and Improves Memory in Mouse Models of Alzheimer's Disease
- (2010) P. Garcia et al. JOURNAL OF NEUROSCIENCE
- Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian Epidermis
- (2009) Kim B. Jensen et al. Cell Stem Cell
- iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
- (2009) Uros Rajcevic et al. MOLECULAR & CELLULAR PROTEOMICS
- Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival
- (2009) Camilla Holmlund et al. NEUROPATHOLOGY
- A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions
- (2008) Simone P. Niclou et al. FASEB JOURNAL
- Lrig1 Is an Endogenous Inhibitor of Ret Receptor Tyrosine Kinase Activation, Downstream Signaling, and Biological Responses to GDNF
- (2008) F. Ledda et al. JOURNAL OF NEUROSCIENCE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
- (2008) M A Stutz et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started